Glycosides and Thymidine from the Mollusk Cryptochiton stelleri

I. Kapustina,T. N. Makar’eva,A. I. Kalinovskii,V. Stonik

DOI: https://doi.org/10.1007/s10600-005-0092-0

Chemistry of Natural Compounds

Abstract:

What problem does this paper attempt to address?

Multivariable Analysis of Factors Associated with Hospital Readmission Following Pancreaticoduodenectomy for Malignant Diseases

Zhu Zi-yi,He Ji-kai,Wang Yi-fan,Liang Xiao,Yu Hong,Wang Xian-fa,Cai Xiu-jun

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2011.07.014

2011-01-01

Abstract:Background Readmission rates after pancreaticoduodenectomy (PD) for malignant diseases have a significant impact on survival rate. Identification of risk factors for readmission may improve discharge plans and postoperative care. Data exist on the morbidity and mortality of patients undergoing PD, but there are few reports about hospital readmissions after this procedure. Our aims were to evaluate the proportion and reasons for readmissions after PD for malignant diseases, the factors influencing readmissions, and to analyze the relationship between readmission rate and survival rate.Methods Four hundred and thirty-six patients, who had undergone PD for malignant diseases in our centre from October 1999 to October 2009, a 10-year period, excluding perioperative (30-day) mortality, were identified. All readmissions within 1 year following PD were analyzed with respect to timing, location, reasons for readmission and outcome. We reviewed the hospitalization and readmissions for patients undergoing PD, and compared patients requiring readmission to patients that did not require readmission.Results One hundred and forty-five patients (33.26%) were readmitted within 1 year following PD, for further treatment or complications. In those cases, diagnoses associated with high rates of readmission included radiation and/or chemotherapy (48.96%), progression of disease (11.72%), infection (11.72%), gastrointestinal dysfunction/obstruction (6.20%), surgery-related complications (2.76%) and pain (4.14%). The proportion of T4 in readmission group was lower than no readmission group (P < 0.05). The proportion of node positive cases in readmission group was much higher than no readmission group (P < 0.01). The number of readmission for complications reduced gradually in the first three months, and reached a second peak in the sixth and seventh month. Median survival was lower for the readmission group compared with the no readmission group (21 versus 46 months, P=0.024).Conclusion These results may assist in both anticipating and facilitating postoperative care as well as managing patient expectations. Chin Med J 2011;124(7):1022-1025
Prognostic factors for survival and surgical complications in Whipple's pancreatoduodenectomy during a 10-year experience

Francisco Reyna-Sepúlveda,Gerardo Muñoz-Maldonado,Edelmiro Pérez-Rodríguez,Fabiola Hernández-Trejo,Asdruval Guevara-Charles,Marco Hernández-Guedea

DOI: https://doi.org/10.24875/CIRU.18000526

Abstract:Background: Periampullary neoplasms account for over 30,000 cancer-related deaths per year in the United States. Pancreaticoduodenectomy (PD) is considered the surgical standard and is the only curative treatment option for these pathologies. Objective: The objective of this study was to report the prognostic factors in survival and surgical complications in PD. Materials and methods: A total of 178 cases are reported, several variables were reviewed and the same surgical technique was used by the same surgeon. Results: A total of 151 PD were reviewed. The most common initial symptoms were jaundice, 111 (73%), abdominal pain, 20 (13%), and oral intolerance, 10 (6%). Poor prognostic factors for survival were the presence of a previous pathology, days of hospitalization, positive margins, and weight loss. Discussion: With the experience gained, a decrease in surgical time, intraoperative bleeding, and transfusions performed was achieved. Our complication rate remained at 20%, lower than that reported in literature. Conclusion: PD is the only option of cure for patients with pancreatic and periampullary tumors. This procedure has been linked to high morbidity and mortality even in high-volume centers. A pancreatic fistula is the most feared complication; therefore, multiple pancreatojejunostomy techniques have been described in literature. It is important to continue reporting these cases to reach a consensus on this technique.
Total Laparoscopic Versus Open Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: a Propensity Score Matching Analysis with Meta-Analysis

Ke Chen,Yu Pan,Yi-ping Mou,Chao-jie Huang,Jia-fei Yan,Ren-chao Zhang,Miao-zun Zhang,Guan-yu Wang,Xian-fa Wang,Qi-long Chen

DOI: https://doi.org/10.21203/rs.3.rs-20225/v1

2020-01-01

Abstract:Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer mortality worldwide. Total laparoscopic pancreaticoduodenectomy (TLPD) have been used in the treatment of benign and low-grade diseases on the pancreatic head. It is necessary to expand the current knowledge on the feasibility and safety of TLPD for PDAC treatment. We aimed to assess the surgical and oncological outcomes of TLPD for patients with PDAC by comparing them with open pancreaticoduodenectomy (OPD). Methods Data regarding patients who underwent pancreaticoduodenectomy for PDAC treatment from January 2013 to January 2019 in our hospital were obtained. Baseline characteristics, intraoperative effects, postoperative recoveries, and survival outcomes were compared. To overcome selection bias, we performed a 1:1 match using propensity score matching (PSM) between TLPD and OPD. We also conducted a systematic review and meta-analysis. Results The original cohort included 276 patients (TLPD; 98 patients, OPD; 178 patients). After PSM, there were 89 patients in each group and the patient demographics were well matched. Of the 98 patients who underwent TLPD, 8 (8.2%) required conversions to laparotomies. Compared to OPD, TLPD could be performed with longer operative times, had less blood loss, and had lower overall morbidities. Regarding oncological and survival outcomes, there were no significant differences in tumor size, R0 resection rates and tumor stages between groups. However, TLPD had an advantage over OPD in terms of retrieved lymph nodes (21.9 ± 6.6 vs. 18.9 ± 5.4, p < 0.01). There were no statistically signiﬁcant differences between the groups in recurrence patterns, and the 3-year recurrence-free and overall survival rates were comparable between the two groups. Meta-analysis further confirmed that the TLPD were associated with longer operative times, less blood loss, shorter hospitalizations, lower morbidities, and a greater number of retrieved lymph nodes. Conclusions TLPD are feasible and oncologically safe procedures for PDAC treatments. Postoperative outcomes and long-term survival after TLPD are superior, or not inferior, to OPD, and could be a promising alternative to open surgery for PDAC treatments. Our findings should be further evaluated by multicenter or randomized controlled trials.
Relationship Between Non-Alcoholic Fatty Liver Disease and the Perioperative and Short-Term Prognosis of Breast Cancer

Xinjue He,Yi Chen,Chengfu Xu,Ping Xu,Youming Li,Chaohui Yu

DOI: https://doi.org/10.2139/ssrn.3288886

2018-01-01

Abstract:Background: Although non-alcoholic fatty liver disease (NAFLD) has been shown to be a multisystem disease complicated with extrahepatic malignancies, there is limited data on the association between NAFLD and breast cancer. Here, we conducted a retrospective cohort study to investigate the relationship between NAFLD, and the perioperative and short-term outcomes of breast cancer in Chinese population. Methods: A total of 140 patients with breast cancer who underwent mastectomy at our center in 2016 were enrolled, including 70 patients with NAFLD and 70 patients without NAFLD. NAFLD was diagnosed mainly on the basis of ultrasonography, and the severity was graded by noninvasive indicators. Breast cancer was diagnosed by postoperative pathology; its perioperative outcomes were assessed based on the duration of hospitalization, cost, surgery-related factors, and perioperative complications, while the short-term prognosis was assessed based on short-term metastasis or recurrence. Results: Among patients with breast cancer who underwent mastectomy, those with NAFLD had a longer duration of hospitalization (6.0 vs. 5.0 days, p = 0.014) and incurred higher medicine cost (4470.0 vs. 3202.2 yuan, p = 0.011) than those of patients without NAFLD. Additionally, patients with NAFLD had a longer duration of operation (2.0 vs. 1.5 hours, p = 0.002) and experienced more blood loss (20.0 vs. 20.0 mL, p = 0.015) than patients without NAFLD did. There was no significant difference in the perioperative complications and short-term metastasis or recurrence between the groups. The effect of NAFLD was significant in smaller tumors, infiltrating ductal and lobular carcinomas, and moderately differentiated tumors. The perioperative outcomes worsened with increase in the severity of NAFLD. Conclusions: NAFLD negatively affects the perioperative outcomes of breast cancer, and the outcomes worsen with the severity of NAFLD.Funding Statement: This study was supported by Science Foundation of Health Bureau of Zhejiang Province, No. 2017183691 (To Yi Chen), National Natural Science Foundation of China, No. 8170054 (To Yi Chen), Natural Science Foundation of Zhejiang Province, No. LY17H030006 (To Ping Xu).Declaration of Interests: The authors declare that they have no competing interestsEthics Approval Statement: The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang University.
Influence of Jaundice on Pancreatoduodenectomy

CAO Liping,CHEN Baiwen,PENG Shuyou

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2006.07.004

2006-01-01

Abstract:Objective To investigate the influence of jaundice on pancreatoduodeneetomy(PD). Methods The clinical data of 195 cases undergoing PD in our hospital from January 1998 to June 2004 were reviewed.These patients were divided into 3 groups according to clinical manifestation of with or without jaundice and the TIBL level.There was no jaundice in the patients in group A.In group B, the patients had jaundice and the TIBL171μmol/L.In group C,the patients had jaundice and TIBL ≥171 μmol/L.The general condition and clinical results were compared among the 3 groups one by one.The data were analyzed with SPSS software.Results The blood loss during operation and the rate of upper gastrointestinal hemorrhage were significantly higher in group C than in group B(P 0.05).The rate of postoperative renal failure was markedly higher in group C than in group A and group B(P0.05).Conclusions Obstructive jaundice is one of the risk factors of PD.However,if there is good perioperative preparation for patients with severe jaundice,one-stage PD can be per- formed in those who have no severe associated diseases.
Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic outcomes and long-term survival

Ke Chen,Yucheng Zhou,Weiwei Jin,Qicong Zhu,Chao Lu,Nan Niu,Yuanyu Wang,Yiping Mou,Zheling Chen

DOI: https://doi.org/10.1007/s00464-019-06968-8

2019-01-01

Surgical Endoscopy

Abstract:Objective The study aimed to compare the oncologic outcomes and long-term survival of laparoscopic pancreaticoduodenectomy (LPD) and open pancreaticoduodenectomy (OPD) for patients diagnosed with pancreatic ductal adenocarcinoma (PDAC). Background Substantial evidence demonstrated that LPD is technically safe and feasible with perioperative outcomes equivalent to that of OPD. However, for patients with malignancy, especially PDAC, the oncologic outcomes and long-term survival of patients who underwent LPD remains to be elucidated. Methods Studies on LPD for the treatment of PDAC published before December 25, 2018 were searched online. The oncologic outcomes (e.g., numbers of lymph nodes retrieved, negative margin (R0) resection), and long-term survival (postoperative survival from 1 to 5 year) of LPD were compared to that of ODP. Results After screening 1507 studies, six comparative cohort studies, which reported the oncologic outcomes and long-term survival of patients with PDAC were included. No significant difference was found between LPD and OPD regarding lymph nodes harvested (OR 1.96, 95% CI − 1.17 to 5.09, p = 0.22), R0 rate (OR 1.44, 95% CI 1.00 to 2.06, p = 0.05), number of positive lymph nodes (OR − 0.44, 95% CI − 1.06 to 0.17, p = 0.16), rate of adjuvant treatment (OR 1.04, 95% CI 0.68 to 1.59, p = 0.86) and time to adjuvant treatment (OR − 6.21, 95% CI − 16.00 to 3.59, p = 0.21). LPD showed similar 1-year (OR 1.20, 95% CI 0.87 to 1.65, p = 0.28), and 2-year survival (OR 1.25, 95% CI 0.94 to 1.66, p = 0.13) to that of OPD. The 3-year (OR 1.50, 95% CI 1.12 to 2.02, p = 0.007), 4-year (OR 1.73, 95% CI 1.02 to 2.93, p = 0.04), and 5-year survival (OR 2.11, 95% CI 1.35 to 3.31, p = 0.001) were significantly longer in LPD group. Conclusion For the treatment of PDAC, the oncologic outcomes of LPD were equivalent to that of OPD; LPD seemed promising regarding the postoperative long-term survival.
LDP vs ODP for pancreatic adenocarcinoma: a case matched study from a single-institution

Miaozun Zhang,Ren Fang,Yiping Mou,Ronggao Chen,Xiaowu Xu,Renchao Zhang,Jiafei Yan,Weiwei Jin,Harsha Ajoodhea

DOI: https://doi.org/10.1186/s12876-015-0411-2

2015-01-01

BMC Gastroenterology

Abstract:Background Laparoscopic distal pancreatectomy (LDP) showed advantage of perioperation outcomes for benign and low-grade tumor of the pancreas. The application of LDP for pancreatic ductal adenocarcinoma (PDAC) didn’t gain popular acceptance and the number of LDP for PDAC remains low. We designed a case-matched study to analysis the short- and long-term outcomes of the patients undergoing either Laparoscopic distal pancreatectomy or open distal pancreatectomy for PDAC. Method From 2003 to 2013, 17 patients were underwent LDP and 34 patients were underwent ODP for PDAC were matched by tumor size, age and body mass index (BMI). The two groups’ demographic information, perioperative outcomes and survival data were compared. Results Baseline characteristics were comparable between the LDP and ODP groups. The intraoperative blood loss, first flatus, first oral intake and postoperative hospital stay were significantly less in LDP group than ODP group (50 ml vs400ml, P = 0.000; 3d vs 4d, P = 0.001; 3d vs 4d, P = 0.003; 13d vs 15.5d, P = 0.022). The mean operation time, overall postoperative morbidity and postoperative pancreatic fistula rates were similar in the two groups. 5 patients (29.4 %) in LDP group and 7 patients (20.6 %) in ODP group underwent extended resections. There were no significant differences in tumor sizes (3.5 cm vs 3.9 cm, P = 0.664) and number of harvested lymph nodes (9 vs8 P = 0.534). The median overall survival for both groups was 14.0 months. Cox proportional hazards analysis showed extended resections, R1 resection, perineural invasion and tumor differentiation were associated with worse survival. Conclusion LDP is technically feasible and safe for PDAC in selected patients and the short-term oncologic outcomes were not inferior to ODP in this small sample study. However the long-term oncologic safety of LDP for PDAC has to be further evaluated by multicenter or randomized controlled trials.
Post-pancreatectomy Acute Pancreatitis after Pancreaticoduodenectomy: A Distinct Clinical Entity

Haoda Chen,Chao Wang,Ziyun Shen,Weishen Wang,Yuanchi Weng,Xiayang Ying,Xiaxing Deng,Baiyong Shen

DOI: https://doi.org/10.1097/sla.0000000000005605

IF: 13.787

2022-07-18

Annals of Surgery

Abstract:OBJECTIVE: This study aimed to characterize post-pancreatectomy acute pancreatitis (PPAP) after pancreaticoduodenectomy (PD) in a high-volume center.BACKGROUND: The International Study Group for Pancreatic Surgery (ISGPS) has recently proposed a new definition and grading scale of PPAP, but specific studies are lacking.METHODS: Patients who underwent PD from 2020 to 2021 were retrospectively reviewed. PPAP was defined based on the ISGPS definition: sustained elevation of serum amylase levels for least the first 48 hours postoperatively and radiologic alterations consistent with PPAP.RESULTS: Among a total of 716 patients who were finally analyzed, PPAP occurred in 152 (21.2%) patients. Patients with PPAP were associated with significantly higher incidences of postoperative pancreatic fistula (POPF) (40.8% vs. 11.7%, P<0.001), major complications (13.8% vs. 6.6%, P=0.004) and biliary leak (11.8% vs. 4.6%, P=0.001). Among them, 8 patients developed grade C PPAP leading to organ failure, reoperation, or death. Patients developing PPAP alone also demonstrated a statistically significantly increased rate of major complications than those without PPAP or POPF. On the other hand, no differences were found in postoperative outcomes in patients with POPF in terms of whether they were associated with PPAP.CONCLUSION: PPAP is a distinct complication after PD with distinctive clinical outcomes. A part of PPAP presents as an inflammatory process in the early postoperative period but sometimes could lead to necrotizing pancreatitis or other severe clinical scenarios, and another part of PPAP would lead to anastomotic failure that accounts for a great proportion of POPF occurrence.

surgery
Association of preoperative CT‐scan features and clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy: a meta‐analysis

Ahmad Madankan,Ali Jaliliyan,Pantea Khalili,Shayan Eghdami,Hesam Mosavari,Seyyed Amir Yasin Ahmadi,Amirreza Izadi,Ali Hosseininasab,Foolad Eghbali

DOI: https://doi.org/10.1111/ans.19033

IF: 1.7

2024-06-07

ANZ Journal of Surgery

Abstract:This systematic review and meta‐analysis of 38 studies found that smaller pancreatic duct diameter (PDD) and decreased pancreatic parenchymal thickness (PPT) on preoperative CT scans are significant predictors of clinically relevant postoperative pancreatic fistula (CR‐POPF) after pancreaticoduodenectomy. Age also correlates with an increased risk of this complication. Background Clinically relevant postoperative pancreatic fistula (CR‐POPF) is a significant complication after pancreaticoduodenectomy. CR‐POPF is associated with various adverse outcomes, including high mortality rates. Identifying complication predictors for CR‐POPF, such as preoperative CT scan features, including pancreatic attenuation index (PAI) and pancreatic duct diameter (PDD), is critical. This systematic review and meta‐analysis consolidate existing literature to assess the impact of these variables on CR‐POPF risk. Methods Our comprehensive search, conducted in May 2023, covered PubMed, Scopus, Embase, and Web of Science databases. Inclusion criteria encompassed peer‐reviewed cohort studies on pancreaticoduodenectomy, focusing on preoperative CT scan data. Case reports, case series, and studies reporting distal pancreatectomy were excluded. The quality assessment of included articles was done using New‐Castle Ottawa Scale for cohort studies. Statistical analysis was carried out using Review Manager 5. This study was registered at the International Prospective Register of Systematic Reviews database (PROSPERO) on 12 May 2023 (registration number: CRD42023414139). Results We conducted a detailed analysis of 38 studies with 7393 participants. The overall incidence of CR‐POPF was 24%. Multiple linear regression analyses revealed that PDD and pancreatic parenchymal thickness were significantly associated with CR‐POPF. Conclusion Our systematic review and meta‐analysis shed light on CT scan findings for predicting CR‐POPF after Whipple surgery. Age, PDD, and pancreatic parenchymal thickness significantly correlate with CR‐POPF.

surgery
The Signal Intensity Ratio of Pancreas to Spleen in Magnetic Resonance Imaging Can Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy

Masashi Tsunematsu,Koichiro Haruki,Yoshihiro Shirai,Shinji Onda,Kenei Furukawa,Norimitsu Okui,Kyohei Abe,Taro Sakamoto,Takeshi Gocho,Toru Ikegami

DOI: https://doi.org/10.1097/mpa.0000000000002306

2024-02-14

Pancreas

Abstract:Objectives Signal intensity ratio of pancreas to spleen (SI ratio p/s ) on fat-suppressed T1-weighted images of magnetic resonance imaging has been associated with pancreatic exocrine function. We here investigated the predictive value of the SI ratio p/s for the development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy (PD). Materials and Methods This study comprised 208 patients who underwent PD. NAFLD was defined as a liver-to-spleen attenuation ratio of <0.9 calculated by a computed tomography 1 year after surgery. SI ratio p/s was calculated by dividing the average pancreas SI by the spleen SI. We retrospectively investigated the association of clinical variables including the SI ratio p/s and NAFLD by univariate and multivariate analyses. Results NAFLD after 1 year was developed in 27 patients (13%). In multivariate analysis, the SI ratio p/s < 1 ( P < 0.001) was an independent predictor of incidence of NAFLD. The SI ratio p/s < 1 was associated with low amylase level of the pancreatic juice ( P < 0.001) and progressed pancreatic fibrosis ( P = 0.017). According to the receiver operating characteristics curve, the SI ratio p/s had better prognostic ability of NAFLD than the remnant pancreas volume. Conclusions The SI ratio p/s is useful to predict NAFLD development after PD. Moreover, the SI ratio p/s can be a surrogate marker, which represents exocrine function of the pancreas.

gastroenterology & hepatology
Characterization of Pancreatic Fistula after Post-pancreatectomy Acute Pancreatitis

Haoda Chen,Weishen Wang,Ningzhen Fu,Wentao Xia,Hongzhe Li,Yuchen Ji,Jingyu Zhong,Jiancheng Wang,Xiaxing Deng,Zhiwei Xu,Yuanchi Weng,Baiyong Shen

DOI: https://doi.org/10.1097/sla.0000000000006277

IF: 13.787

2024-03-19

Annals of Surgery

Abstract:Objective: This study aimed to investigate the clinical significance and risk factors of postoperative pancreatic fistula (POPF) after post-pancreatectomy acute pancreatitis (PPAP) in patients who underwent pancreaticoduodenectomy (PD). Summary Background Data: PPAP has been recognized as a critical factor in the pathophysiology of POPF after PD. Methods: A total of 817 consecutive patients who underwent elective PD between January 2020 and June 2022 were included. PPAP and POPF were defined in accordance with the International Study Group for Pancreatic Surgery (ISGPS) definitions. Multivariate logistic analyses were performed to investigate the risk factors for POPF. Comparisons between PPAP-associated POPF and non-PPAP-associated POPF were made to further characterize this intriguing complication. Results: Overall, 159 (19.5%) patients developed POPF after PD, of which 73 (45.9%) occurred following PPAP, and the remaining 86 (54.1%) had non-PPAP-associated POPF. Patients with PPAP-associated POPF experienced significantly higher morbidity than patients without POPF. Multivariate analyses revealed distinct risk factors for each POPF type. For PPAP-associated POPF, independent risk factors included estimated blood loss >200 mL (OR 1.93), MPD ≤3 cm (OR 2.88), and soft pancreatic texture (OR 2.01), largely overlapping with FRS (Fistula Risk Score) elements. On the other hand, non-PPAP-associated POPF was associated with age >65 years (OR 1.95), male (OR 2.10), and MPD ≤3 cm (OR 2.57). Notably, among patients with PPAP, the incidence of POPF consistently hovered around 50% regardless of the FRS stratification. Conclusions: PPAP-associated POPF presents as a distinct pathophysiology in the development of POPF after PD, potentially opening doors for future prevention strategies targeting the early postoperative period.

surgery
Prognostic Value of Para-Aortic Lymph Node Metastasis and Dissection for Pancreatic Head Ductal Adenocarcinoma: a Retrospective Cohort Study

Yecheng Xu,Feng Yang,Deliang Fu

DOI: https://doi.org/10.1097/jp9.0000000000000159

2024-01-01

Journal of Pancreatology

Abstract:Background:. Para-aortic lymph node (PALN) metastasis affects approximately 20% of patients with pancreatic ductal adenocarcinoma (PDAC). However, the prognostic significance of PALN metastases and dissection remains unclear. Methods:. This retrospective cohort study included patients with PDAC of the pancreatic head who had undergone pancreaticoduodenectomy (PD) at our center between January 2017 and December 2020. Results:. A total of 234 patients were included in the study. PALN dissection improved the median overall survival (OS) without statistical significance (24.1 vs 18.1 months, P = .156). The median recurrence-free survival was significantly longer in the PALN-dissection group than the group without PALN dissection (18.2 vs 11.6 months, P = .040). Conversely, there were no significant differences in the long-term prognosis between the PALN-positive and PALN-negative subgroups in the PALN-dissection group. Multivariate analysis showed that PALN metastasis was not an independent risk factor for OS (hazard ratio: 0.831, 95% confidence interval: 0.538–1.285, P = .406). Conclusions:. For patients with pancreatic head ductal adenocarcinoma, PD with PALN dissection may achieve survival prolongation and bridge the survival gap between patients with and without PALN metastasis without significantly increasing the perioperative risks.
Molecular and functional adaptations in deep-sea hemoglobins.

S. Hourdez,R. Weber

DOI: https://doi.org/10.1016/J.JINORGBIO.2004.09.017

IF: 4.336

Journal of Inorganic Biochemistry

Abstract:
The biology and serology of Epstein-Barr virus (EBV) infections.

G. Klein

IF: 1.318

1976-07-01

Bulletin du Cancer

Abstract:The Epstein-Barr virus (EBV), carried by the majority of the world's adult human population, is closely associated with three known human diseases; infectious mononucleosis IM), Burkitts lymphoma (BL) and nasopharyngeal carcinoma (NPC). It is now generally accepted that EBV plays an active role in the etiology of BL and NPC rather than simply being a "passenger". Considerable evidence also argues for the participation of "co-factors" in these two diseases. Environmental co-factors appear needed to explain the peculiar geographical distribution of BL. Among various possibilities that must be considered are insect-transmitted agents that could lead to eventual immunosuppression and/or stimulate further proliferation of EBV-transformed cells, thereby permitting an additional cytogenetic evolution towards malignancy. Recent studies have uncovered a possible cytogenetic co-factor in the ethiology of BL; the 8-14 chromosomal translocation. Genetic co-factors, on the other hand, are likely to be involved in the etiology of NCP. EBV is a B-cell associated virus. Carrier lymphoid cell lines obtained either by in vitro "immortalization" of human cord-blood lymphocytes or by explants from IM and African BL donors harbor multiple copies of the EBV genome, and viral genetic sequences have also been directly detected in biopsies of African BL. The state of the viral genomes in the carrier cell appears to be such that some are integrated into the cellular DNA while others exist as free, covalently closed circular molecules.
Contraindications to Estrogen Therapy in Postmenopausal Women

M. Beattie

Abstract:ormone therapy (HT) is one of the most prescribed medical regimens in the United States. Before the July 2002 publication of the opposedestrogen arm of the Women’s Health Initiative (WHI), which linked at least 3 years of HT to an elevated risk of invasive breast cancer, an estimated 38% of postmenopausal women in this country were taking HT. In 2000, this group accounted for 46 million prescriptions for conjugated equine estrogen (CEE) and 23 million prescriptions for CEE plus medroxyprogesterone acetate (MPA). Approved indications for HT as stipulated by the US Food and Drug Administration (FDA) include the relief of menopausal symptoms and the prevention of osteoporosis. Prevention of fractures (associated with decreased bone density), vasomotor instability (hot flashes), and atroW O M E ’ S H E A LT H Current Status of Postmenopausal Hormone Therapy
Postoperative Recovery after Pylorus-Preserving Pancreaticoduodenectomy Versus Conventional Whipple Operation: an Analysis of 112 Consecutive Cases

虞先浚,倪泉兴,张群华,傅德良,陈宗佑

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2003.08.009

2003-01-01

Abstract:Objective To analyze the postoperative recovery after pylorus preserving pancreaticoduodenectomy (PPPD) versus conventional Whipple operation. Methods The postoperative recovery was compared between 49 patients receiving PPPD and 63 undergoing Whipple operation from 1998 to 2001. Results Operative duration, postoperative hospital stay, incidence of complications were lower but gastric suction time and delayed gastric emptying occurrence were higher in patients receiving PPPD than in those undergoing Whipple operation. The patients with the history of abdominal operation and those with intraabdominal complications showed a higher incidence of delayed gastric emptying (35 5%:11 1%, 46 2%:9 3%, P0 05). Conclusions PPPD is a safe surgical procedure and the pylorus preservation does not influence the incidence of delayed gastric emptying and the postoperative recovery.
Vater’s Ampullary Carcinoma Increases the Risk of Clinically Relevant Postoperative Pancreatic Fistula after Pancreaticoduodenectomy: A Retrospective and Propensity Score-Matched Analysis

Yang Yifei,Fu Xu,Zhu Saisai,Cai Zhenghua,Qiu Yudong,Mao Liang

DOI: https://doi.org/10.1186/s12876-022-02128-w

2022-01-01

BMC Gastroenterology

Abstract:Abstract Background Postoperative pancreatic fistula (POPF) is a frequent complication after pancreaticoduodenectomy (PD). This study aimed to investigate the impact of Vater’s ampullary carcinoma (VAC) on clinically relevant POPF (CR-POPF) in patients undergoing PD. Methods Clinical data were gathered retrospectively from January 2018 to December 2020 for all patients undergoing PD. The univariate and multivariate analysis were used to identify independent risk factors of CR-POPF. A propensity score-matched (PSM) analysis at a ratio of 1:1 was performed to minimize bias from baseline characteristics between VAC and non-VAC groups. Main postoperative complications were compared between the two groups after PSM. Results In 263 patients, 94 (35.7%) patients were diagnosed as VAC. CR-POPF occurred in 99 (37.6%) patients and VAC was identified as an independent risk factor of CR-POPF in multivariate logistic regression analysis (OR = 0.548, 95% CI = 0.327–0.920, P = 0.023). After PSM, there were similar baseline characteristics between the VAC and non-VAC group. Moreover, VAC group had a higher rate of CR-POPF (P = 0.025) and intra-abdominal infection (P = 0.015) compared to the non-VAC group. Conclusions In patients undergoing PD, VAC increases the risk of CR-POPF and several other postoperative complications.
Delayed gastric emptying after Pancreaticoduodenectomy: a propensity score-matched analysis and clinical Nomogram study

Xianlei Cai,Miaozun Zhang,Chao Liang,Yuan Xu,Weiming Yu

DOI: https://doi.org/10.1186/s12893-020-00809-5

2020-07-09

BMC Surgery

Abstract:Abstract Background Delayed gastric emptying (DGE) is a common and frustrating complication of pancreaticoduodenectomy (PD). Studies suggest that surgical methods and other clinical characteristics may affect the occurrence of DGE. Nevertheless, the results of such studies are conflicting. The objective of this work was to perform a propensity score matching analysis to compare the differences between pylorus-preserving pancreaticoduodenectomy (PPPD) and pylorus-removing pancreaticoduodenectomy (PrPD) and to develop and validate a nomogram to predict the probability of severe DGE (SDGE). Methods This retrospective study enrolled patients who underwent PD at our institution from December 2009 to December 2018. Propensity score matching was applied at a ratio of 1:1 to compare PPPD and PrPD groups. We compared incidence of complications, DGE, lengths of hospital stay, hospitalization costs, and mortality. Univariate and multivariate logistic regression analysis were performed to identify potential risk factors of severe DGE. Finally, a nomogram was developed and validated to predict severe DGE. Results The PPPD group had a significantly higher rate of postoperative pancreatic fistula (29.9% versus 17.4%, P < 0.05) and less blood loss (463.7 ml versus 694.9 ml, P < 0.05). After propensity score matching, the PPPD group had a significantly higher rate of postoperative DGE (19.2% versus 3.8%, P < 0.05), especially severe DGE (17.3% versus 0%) than the PrPD group. There were no significant differences in terms of lengths of hospital stay, hospitalization costs or mortality between the groups. Surgical method, biliary leakage, abdominal infection, and diabetes were independent risk factors for SDGE. The nomogram predicted SDGE with a training C - index of 0.798 and a validation C - index of 0.721. Conclusion PPPD increases the risk of DGE than PrPD, especially SDGE. Our prediction nomogram gives good prediction of SDGE after pancreaticoduodenectomy.

surgery
Long-term Outcomes of Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Chinese Multi-Center Prospective Randomized Controlled Trial.

Weishen Wang,Wenhui Lou,Zhiwei Xu,Haoda Chen,Ziyun Shen,Xiaxing Deng,Chenghong Peng,Yingbin Liu,Baiyong Shen

DOI: https://doi.org/10.1016/j.jare.2022.09.011

IF: 12.822

2023-01-01

Journal of Advanced Research

Abstract:Introduction: The value of extended lymphadenectomy in pancreatoduodenectomy (PD) has been dis-cussed by five randomized controlled studies. However, the limitations in the studies made their conclu-sions not sufficiently reliable. Objectives: This multi-center randomized controlled study was designed to clarify the efficacy of extended lymphadenectomy in PD for pancreatic ductal adenocarcinoma (PDAC).Methods: From December 2016 to October 2018, 170 consecutive patients undergoing PD were enrolled and randomized to standard or extended lymphadenectomy for the treatment of PDAC from three high - volume institutions in China. Demographic, pathological characteristics and survival data of these patients were collected and analyzed. No neoadjuvant treatment was performed. The primary endpoint was the 3-year overall survival.Results: For all patients, the 3-year survival rate was 25.88 %. There was no between-group difference in 3-year survival rate (27.16 % vs 24.72 % p = 0.717). The median survival time for the standard group was 18 months, while for the extended group it was 15 months. The demographic and pathological charac-teristics were similar between groups. More positive lymph nodes could be found in the extended group (2.34 & PLUSMN; 3.46 vs 1.41 & PLUSMN; 2.12, p = 0.035), which led to nodule stage migration. All patients received chemotherapy. But patients in extended group were more likely to fail in completion of all-cycles chemotherapy before recurrence (31.46 % vs 17.28 %, p = 0.032). Incomplete chemotherapy before recur-rence, higher N status and abnormal CA125 were independent risk factors for 1-year survival (p < 0.001, 95 % CI 0.076-0.368; p = 0.017, 95 % CI 1.113-3.021; p = 0.021, 95 % CI 1.136-4.960, respectively), which was higher in the standard group (75.31 % vs 58.43 %, p = 0.020).Conclusion: The extended lymphadenectomy in PD did not improve the long-term survival in patients with PDAC. Patients with extended lymphadenectomy had a worse 1-year overall survival. However, the nodule stage migration facilitated by the extended lymphadenectomy contributed to the precise tumor staging.& COPY; 2022 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Prognostic Impact of Para-Aortic Lymph Node Metastasis in Resected Non-Pancreatic Periampullary Cancers

Kaival Gundavda,Amit Chopde,Avinash Pujari,Bhaskar Reddy,Akash Pawar,Anant Ramaswamy,Vikas Ostwal,Shraddha Patkar,Manish Bhandare,Shailesh V. Shrikhande,Vikram A. Chaudhari

DOI: https://doi.org/10.1245/s10434-024-15847-z

IF: 4.339

2024-07-20

Annals of Surgical Oncology

Abstract:Abstract Background Surgery remains debatable in para-aortic lymph node (PALN, station 16b1) metastasis in non-pancreatic periampullary cancer (NPPAC). This study examined the impact of PALN metastasis on outcomes following pancreaticoduodenectomy (PD) in NPPAC. Methods A retrospective analysis of patients with NPPAC who were explored for PD with PALN dissection was performed. Based on the extent of nodal involvement on final histopathology, they were stratified as node-negative (N0), regional node involved (N+) and metastatic PALN (N16+) and their outcomes were compared. Results Between 2011 and 2022, 153/887 PD patients underwent a PALN dissection, revealing N16+ in 42 patients (27.4%), of whom 32 patients underwent resection. The 3-years overall survival (OS) for patients with N16+ was 28% (95% confidence interval [CI] 13–60%), notably lower than the 67% (95% CI 53–83.5%; p = 0.007) for those without PALN metastasis. Stratified by nodal involvement, the median OS for N+ and N16+ patients was similar (28.4 months and 26.2 months, respectively). The N0 subgroup had a significantly longer 3-years OS of 87.5% (95% CI 79–96.7%; p = 0.0051). Interestingly, 10 patients not offered resection following N16+ identified on frozen section had a median survival of only 9 months. The perioperative morbidity and mortality in patients undergoing PD with PALN dissection were similar to standard resections. Conclusion In a select group of patients with NPPAC, PD in isolated PALN metastasis was associated with improved OS. The survival in this group of patients was comparable with regional node-positive patients and significantly better than palliative treatment alone.

oncology,surgery

Glycosides and Thymidine from the Mollusk Cryptochiton stelleri

Multivariable Analysis of Factors Associated with Hospital Readmission Following Pancreaticoduodenectomy for Malignant Diseases

Prognostic factors for survival and surgical complications in Whipple's pancreatoduodenectomy during a 10-year experience

Total Laparoscopic Versus Open Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: a Propensity Score Matching Analysis with Meta-Analysis

Relationship Between Non-Alcoholic Fatty Liver Disease and the Perioperative and Short-Term Prognosis of Breast Cancer

Influence of Jaundice on Pancreatoduodenectomy

Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic outcomes and long-term survival

LDP vs ODP for pancreatic adenocarcinoma: a case matched study from a single-institution

Post-pancreatectomy Acute Pancreatitis after Pancreaticoduodenectomy: A Distinct Clinical Entity

Association of preoperative CT‐scan features and clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy: a meta‐analysis

The Signal Intensity Ratio of Pancreas to Spleen in Magnetic Resonance Imaging Can Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy

Characterization of Pancreatic Fistula after Post-pancreatectomy Acute Pancreatitis

Prognostic Value of Para-Aortic Lymph Node Metastasis and Dissection for Pancreatic Head Ductal Adenocarcinoma: a Retrospective Cohort Study

Molecular and functional adaptations in deep-sea hemoglobins.

The biology and serology of Epstein-Barr virus (EBV) infections.

Contraindications to Estrogen Therapy in Postmenopausal Women

Postoperative Recovery after Pylorus-Preserving Pancreaticoduodenectomy Versus Conventional Whipple Operation: an Analysis of 112 Consecutive Cases

Vater’s Ampullary Carcinoma Increases the Risk of Clinically Relevant Postoperative Pancreatic Fistula after Pancreaticoduodenectomy: A Retrospective and Propensity Score-Matched Analysis

Delayed gastric emptying after Pancreaticoduodenectomy: a propensity score-matched analysis and clinical Nomogram study

Long-term Outcomes of Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Chinese Multi-Center Prospective Randomized Controlled Trial.

Prognostic Impact of Para-Aortic Lymph Node Metastasis in Resected Non-Pancreatic Periampullary Cancers